相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterizing lipid profiles associated with asymptomatic intracranial arterial stenosis in rural-dwelling adults: A population-based study
Shaoying Wang et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2020)
World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
Miia Kivipelto et al.
ALZHEIMERS & DEMENTIA (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Craig T. January et al.
CIRCULATION (2019)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett et al.
CIRCULATION (2019)
Burden of Cardiovascular Diseases in China, 1990-2016 Findings From the 2016 Global Burden of Disease Study
Shiwei Liu et al.
JAMA CARDIOLOGY (2019)
Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement
Xin Du et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop
Janice B. Schwartz et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis
Tian-Tian Ma et al.
PLOS ONE (2019)
Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II
Lu Gao et al.
AGE AND AGEING (2018)
Social health insurance vs private health insurance in China: Revisit crowd-out effect based on a multiple mediation analysis
Ying Zhang et al.
INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT (2018)
Traditional Chinese Medicine for Cardiovascular Disease Evidence and Potential Mechanisms
Panpan Hao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
The primary health-care system in China
Xi Li et al.
LANCET (2017)
Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)
Jiapeng Lu et al.
LANCET (2017)
The Trends in Cardiovascular Diseases and Respiratory Diseases Mortality in Urban and Rural China, 1990-2015
Weiwei Sun et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2017)
Effects of Macronutrient Distribution on Weight and Related Cardiometabolic Profile in Healthy Non-Obese Chinese: A 6-month, Randomized Controlled-Feeding Trial
Yi Wan et al.
EBIOMEDICINE (2017)
Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases
Lili Wang et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Regional Variations in Medication Usage for Cardiovascular Diseases at the Community Level in China (PURE-China Study)
Yang Jin Gang et al.
BIOMEDICAL AND ENVIRONMENTAL SCIENCES (2017)
Trends in the epidemiology of cardiovascular disease in the UK
Prachi Bhatnagar et al.
HEART (2016)
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Rasha Khatib et al.
LANCET (2016)
Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013
Maigeng Zhou et al.
LANCET (2016)
The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China
Sarah Lewington et al.
JAMA INTERNAL MEDICINE (2016)
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease An Overview of Systematic Reviews
Kunal N. Karmali et al.
JAMA CARDIOLOGY (2016)
Cardiovascular disease in Europe - epidemiological update 2015
Nick Townsend et al.
EUROPEAN HEART JOURNAL (2015)
The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study
Dongfeng Gu et al.
PLOS MEDICINE (2015)
Patterns of cardiovascular drugs prescribed for an elderly Swedish population
Mozhu Ding et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5 million people
Yiping Chen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Multidrug and optimal heart failure therapy prescribing in older general practice populations: a clinical data linkage study
Claire A. Rushton et al.
BMJ OPEN (2014)
Highly prevalent and poorly controlled cardiovascular risk factors among Chinese elderly people living in the rural community
Aiqin Song et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
China's Rural Public Health System Performance: A Cross-Sectional Study
Miaomiao Tian et al.
PLOS ONE (2013)
Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation
Hsiu-Chin Yu et al.
INTERNATIONAL JOURNAL OF STROKE (2012)
AHA/ACCF Secondary Prevention and Risk REduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 Update - A Guideline from the American Heart Association and American College of Cardiology Foundation
Sidney C. Smith et al.
CIRCULATION (2011)
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
Salim Yusuf et al.
LANCET (2011)
Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection
Jennifer Hui-Chun Ho et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World
Laurens M. Niens et al.
PLOS MEDICINE (2010)
Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy
Marco Stramba-Badiale
EUROPEAN HEART JOURNAL (2008)
Health System Reform in China 7 China's health system performance
Yuanli Liu et al.
LANCET (2008)
Interventions for enhancing medication adherence
R. B. Haynes et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort
I Klarin et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2003)
Cost and cost-effectiveness studies in heart failure research
WS Weintraub et al.
AMERICAN HEART JOURNAL (2002)
分享论文
